학술논문
951 – Efficacy and Safety of Glecaprevir/Pibrentasvir Treatment for 8 Weeks in Treatment-Naïve Patients with Chronic Hepatitis C Virus Infection Without Cirrhosis Or with Compensated Cirrhosis: Analysis of Data Pooled from Phase 2 and 3 Studies
Document Type
Abstract
Author
Source
In Gastroenterology May 2019 156(6) Supplement 1:S
Subject
Language
ISSN
0016-5085